|
1) Krahn A, Klein G, Skanes A. Randamized assessment of syncope trial. Circulation. 2001; 104: 46-51
|
|
|
|
2) Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001; 104: 1261-7
|
|
|
|
|
3) Brignole M, Menozzi C, Moya A, et al. Mecha-nism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001; 104: 2045-50
|
|
|
|
|
|
4) Menozzi C, Brignole M, Garcia-Civera R, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002; 105: 2741-5
|
|
|
|
|
|
5) Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J. 2009; 30: 2631-71
|
|
|
|
|
|
6) Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. 2010; 13: 262-9
|
|
|
|
|
|
7) Brignole M, Alboni P, Benditt DG, el al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J. 2004; 25: 2054-72
|
|
|
|
|
|
8) Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006; 27: 1085-92
|
|
|
|
|
|
9) Turley AJ, Tynan MM, Plummer CJ. Time to manual activation of implantable loop recorders--implications for programming recording period: a 10-year single-centre experience. Europace. 2009; 11: 1359-61
|
|
|
|
|